HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enzyme immunoassay of pancreatic oncofetal antigen (POA) as a marker of pancreatic cancer.

Abstract
For the quantitative measurement of pancreatic oncofetal antigen (POA), an enzyme immunoassay for POA has been developed, and is based on the sandwich method using antibody-coupled glass beads and enzyme (peroxidase)-labelled antibody. Serum POA concentrations were increased significantly in patients with pancreatic cancer, but not in those with chronic pancreatitis or other miscellaneous diseases, or in normal subjects. It is concluded that the enzyme immunoassay could be used for the assay of POA and our results show that the determination of serum POA would be useful in the diagnosis of pancreatic cancer.
AuthorsK Nishida, M Sugiura, T Yoshikawa, M Kondo
JournalGut (Gut) Vol. 26 Issue 5 Pg. 450-5 (May 1985) ISSN: 0017-5749 [Print] England
PMID3888788 (Publication Type: Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Immune Sera
  • oncofetal antigens
Topics
  • Antibody Specificity
  • Antigens, Neoplasm (analysis)
  • Chromatography, Gel
  • Chronic Disease
  • Humans
  • Immune Sera (immunology)
  • Immunoenzyme Techniques
  • Pancreatic Neoplasms (diagnosis, immunology, surgery)
  • Pancreatitis (immunology)
  • Postoperative Period

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: